�鶹��ýӰ��

Katherine Kahn

Katherine Kahn

Authors >

Katherine Kahn

Kate is a staff writer at MedPage Today, covering the infectious diseases beat. She brings over fifteen years of corporate and freelance experience in writing for physician and consumer audiences. Kate holds a BA in English Literature from Wilson College, a DVM from Tufts University Cummings School of Veterinary Medicine, and a master’s-level diploma from the New England School of Acupuncture. Before becoming a writer, Kate had clinical practice as a veterinarian and acupuncturist. Her creative writing has won her scholarships and residencies to the Hedgebrook Foundation, Ragdale Foundation, and the Montana Artists’ Refuge.

Connect:

email image

Latest from Katherine Kahn

A photo of a box of paxlovid in blue rubber gloved hands.

An Update on Therapeutics for COVID-19

New research focuses on interventions for highest-risk patients

A photo of an educational mural on the wall of an orphanage in Uganda which reads: SLEEP UNDER A TREATED MOSQUITOE NET

Evidence of Resistance to Standard Malaria Therapy for Severe Cases

High levels of drug resistance could require changes in management strategies, one expert says

A photo of a female nurse tending to a senior woman wearing an oxygen mask and lying in a hospital bed.

RSV Severity, Deaths on Par With Flu and COVID

Pre-vaccine era data suggest underrecognized burden of disease, especially in older adults

2024 YEAR IN REVIEW RSV over a computer rendered cross section of a respiratory syncytial virus.

Year in Review: RSV

Another vaccine option, updated ACIP recommendations, and data on a new monoclonal antibody

2024 YEAR IN REVIEW COVID-19 over a computer rendering of a COVID virus particle.

Year in Review: COVID-19

A look back at newsworthy stories of 2024

Computer rendering of COVID viruses float around a woman who is blowing her nose.

Emerging Insights Into COVID Household Transmission

Got COVID from a sick family member? Maybe not, studies show

IDWeek over a photo of the Los Angeles Convention Center in Los Angeles, CA.

Are Norovirus Vaccines on the Horizon?

Two candidates leverage unique technologies

FDA APPROVED Bivalent RSV prefusion F (RSVpreF) vaccine (Abrysvo) over a computer rendering of respiratory syncytial virus (R

FDA Expands Approval of RSV Vaccine Abrysvo to Include All At-Risk Adults

Decision was based on need for RSV protection in younger people with chronic conditions

IDWeek over a photo of the Los Angeles Convention Center in Los Angeles, CA.

Oral Cephalosporin May Hold Potential for Early Syphilis

Cefixime offers several benefits over penicillin G, researcher says

IDWeek over a photo of the Los Angeles Convention Center in Los Angeles, CA.

Mpox Vaccine in Teens Generates Robust Immune Response, Proves Safe

A vaccine for younger children is urgently needed, researcher says

1

…